Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Brain Neoplasms × Acceptance and Commitment Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 7 Fatigue 6 Breast Neoplasms 5 Anxiety Disorders 3 Psychological Well-Being 2 Pain 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Depression 2 Caregiver Burden 2 Uterine Neoplasms 1 Tuberous Sclerosis 1 Substance-Related Disorders 1 Smoking Cessation 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Regression, Spontaneous 1 Multiple Myeloma 1 Malignant Hepatobiliary Neoplasm 1 Lymphoma 1 Leukemia 1 Hematopoietic Cell Transplantation Recipient 1 Head and Neck Neoplasms 1 Glioblastoma 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1

Interventions

Radiosurgery 104 Temozolomide 94 Bevacizumab 64 Magnetic Resonance Spectroscopy 62 Radiotherapy 60 Carboplatin 29 pembrolizumab 26 Irinotecan 24 Surgical Procedures, Operative 22 Nivolumab 22 Etoposide 20 Radiation 19 Magnetic Resonance Imaging 19 Ipilimumab 19 Erlotinib Hydrochloride 19 Cyclophosphamide 19 Surveys and Questionnaires 18 Aminolevulinic Acid 18 Specimen Handling 15 Pemetrexed 15 Mental Status and Dementia Tests 14 Cisplatin 14 Topotecan 13 Carmustine 13 Neuropsychological Tests 12 Drug Therapy 11 Trastuzumab 10 Saline Solution 10 Imatinib Mesylate 10 Gefitinib 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04722237 2023-08-31

ACT NOW

Nottingham University Hospitals NHS Trust

Phase NA Unknown

Brain Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡